Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Fujifilm Diosynth Biotechnologies, a biologics CDMO and a subsidiary of Fujifilm Corporation, plans to invest more than JYP 200 billion ($1.9 billion) to establish a new large-scale cell-culture production site in the US. The new facility will...

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Fujifilm Diosynth Biotechnologies, Vectura, and Matica Biotechnology. Biologics Manufacturing Thermo Fisher Expands Clinical, Commercial Plasmid DNA Mfg Thermo Fisher...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Fareva, Almac, Batavia Biosciences, and Halix. Chemicals/Chemical API Manufacturing Almac Gets Funding as Part of UK Gov’t's COVID-19 Recovery PlanAlmac Sciences, part of the...

Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company, has announced plans to invest approximately $1.2 billion to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Wacker, Recipharm, and ApiJect. Biologics Manufacturing CureVac, Wacker in Mfg Pact for COVID-19 VaccineCureVac, a Tubingen, Germany-based clinical-stage biopharmaceutical...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Almac, Samsung Biologics, and Cytiva. Chemicals/Chemical API Manufacturing Almac Gets $500,000 Grant for Mfg of COVID-19 Drug RemdesivirAlmac Sciences, a member of the Almac...

Cambrex has announced plans to invest more than $50 million to expand its mid-scale and large-scale active pharmaceutical ingredient (API) manufacturing capacity at its site in Charles City, Iowa. The expansion, which will be operational in early...